Network Sites: EndoNurse Institute Infection Control Today SurgiStrategies Immediate Care Business Renal Business Today Germstop
EndoNurse
Search  
Weekly E-mail Newsletter 

Study Shows Effectiveness of Capsule Endoscopy in Diagnosing Crohn's Disease

04/09/2003

YOQNEAM, Israel, April 9 -- Given Imaging Ltd. today announced that a study published in the European Journal of Gastroenterology & Hepatology 2003, 15:363-367 concluded that the M2A capsule is an effective, sensitive and valuable diagnostic tool in the early diagnosis of Crohn's disease.

"Capsule endoscopy is a superior and more sensitive procedure than barium follow-through and entero-CT in establishing the diagnosis and estimating the extent of Crohn's disease," says Rami Eliakim, MD, head of the department of gastroenterology, Rambam Medical Centre, Bat Galim, Haifa, and president of the Israeli Gastroenterology Association. "It is conceivable that it will become the first line of investigation in patients with early or suspected Crohn's disease."

The study examined twenty patients with suspected Crohn's disease who experienced symptoms which included recurring abdominal pain, weight loss or chronic diarrhea. The mean duration of symptoms before enrollment in the trial was 8 months. The group of patients had to undergo a total of 48 procedures including gastroscopy, colonoscopy, small bowel follow-through, plain abdominal and computer tomography prior to the trial.

Capsule endoscopy established new diagnoses, confirmed existing diagnoses, enlarged the extent of the disease and ruled out the suspicion of Crohn's disease in 70 percent of patients. In comparison, barium follow-through established diagnoses, measured the extent of the disease, and ruled out the suspicion of Crohn's disease in 37 percent of patients. In addition, capsule endoscopy detected all of the lesions diagnosed by barium follow-through and entero-CT, and detected additional lesions that were not detected by other modalities in 47 percent of cases and ruled out lesions detected by other modalities in 16 percent of cases (P<0.05).

For more information, visit http://www.givenimaging.com/ .


Share this article: Email, Slashdot, Digg, Del.icio.us, Yahoo!MyWeb, Windows Live Favorites, Furl
RSS Add this article feed to: RSS, My Yahoo, Newsgator, Bloglines

Post a Comment

Email Email this article Comment Add a comment
Print Printer version Reprints Order reprints
RSS RSS Feed Bookmark Bookmark article





   

Subscribe to EndoNurse Magazine
First Name Last Name
Email

Sponsored LinksEndoNurse Announcements